Royalty Pharma plc announced that it has priced an offering of $1.5 billion of senior unsecured notes, comprised of the following (collectively, the ?Notes?): $500 million of 5.150% Notes due 2029 (the ?2029 Notes?); $500 million of 5.400% Notes due 2034 (the ?2034 Notes?); and $500 million of 5.900% Notes due 2054 (the ?2054 Notes?). The Notes will be guaranteed on a senior unsecured basis by Royalty Pharma Holdings Ltd. The offering is expected to close on June 10, 2024, subject to the satisfaction of customary closing conditions.